Public Profile

Biotech Builders Group

Biotech Builders Group, a prominent player in the biotechnology sector, is headquartered in the United States and operates across key regions globally. Founded in 2015, the company has rapidly established itself as a leader in biopharmaceutical development, focusing on innovative solutions for drug discovery and manufacturing. With a commitment to advancing healthcare, Biotech Builders Group offers a range of services, including custom bioprocess development and regulatory support, distinguished by their cutting-edge technology and expert team. The company has achieved significant milestones, including partnerships with leading pharmaceutical firms, which underscore its strong market position. Recognised for its contributions to the biotech industry, Biotech Builders Group continues to drive progress in therapeutic development, making a meaningful impact on patient care worldwide.

DitchCarbon Score

How does Biotech Builders Group's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

3

Industry Average

Mean score of companies in the Construction Work industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

8

Industry Benchmark

Biotech Builders Group's score of 3 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Biotech Builders Group's reported carbon emissions

Biotech Builders Group, headquartered in the US, currently does not have any publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the company may still be engaged in industry-standard practices aimed at reducing carbon footprints and enhancing sustainability. As the biotech sector increasingly prioritises climate action, Biotech Builders Group's future commitments and strategies will be crucial in aligning with global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Biotech Builders Group's primary industry is Construction work (45), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Biotech Builders Group is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Biotech Builders Group is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Construction Work

PT Impack Pratama Industri Tbk

ID
Construction Work
Updated 11 days ago

LIBERTY ELEVATOR

US
Construction Work
Updated 11 days ago

BAM Nuttall Ltd

GB
Construction Work
Updated 5 days ago

A.P. Construction Company

US
Construction Work
Updated 11 days ago

Stefanutti Stocks Holdings

ZA
Construction Work
Updated 11 days ago

PNW Farmers Coop

US
Construction Work
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers